Reversible posterior leukoencephalopathy syndrome after rituximab.
Zito
Joseph A
JA
Department of Emergency Medicine, Stony Brook University, Stony Brook, NY 11794-8191, USA.
Lee
Christopher C
CC
Johnson
Scott
S
Singer
Adam
A
Vacirca
Jeffrey
J
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D001921:Brain / Q000000981:diagnostic imaging; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000000981:diagnostic imaging; D000069283:Rituximab; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab